AzTrials
AzTrials

Pain, ChronicNCT05723367

Prediction of Clinical Outcome in Lumbar ESPB

An observational study of Pain, Chronic, run by Keimyung University Dongsan Medical Center at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary endpoint of this study was to identify that Perfusion index (PI) has any predictive value for the treatment outcome of cervical radiculopathy Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Pain, Chronic
What is being tested?
lumbar ESPB group where ESPB is performed at L4 with local anesthetics 20ml
How many people
85 participants
Where
1 siteSouth Korea
Study dates
13 Feb 2023to 30 Nov 2023
How long will I take part?
1 Month
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who visit the pain clinic

Who may be able to join

  • Lumbar foraminal stenosis
  • Lumbar central stenosis
  • Lumbar disc herniation
  • Lumbar spondylolisthesis

Who cannot join

  • Infection
  • Pregnancy
  • allergy to local anesthetic agnets
  • Previous lumbar spine surgery

Trial locations and contacts

1 site in 1 country.

South Korea1 site, 1 recruiting
  • Ji Hoon Park

    Daegu, 42601

    Ji Hoon Park, +82532587760, cmjihoon@gmail.com

    J Hee Hong, 82-53-258-7767, swon13@daum.net

    Recruiting

Other trials in South Korea

About this study

Official title: Perfusion Index Value in Predicting the Clinical Outcome of Lumbar ESPB

The primary endpoint of this study was to identify that Perfusion index (PI) has any predictive value for the treatment outcome of cervical radiculopathy

Read the detailed description

The erector spinae plane block (ESPB) is a less invasive, safer, and technically easy alternative procedure to conventional neuraxial anesthetic techniques. In contrast to common neuraxial techniques such as paravertebral and epidural injections, the ESPB targets an interfascial plane which is far from the spinal cord, root, and pleura. First applied to thoracic neuropathic pain, currently ESPB is being applied to postoperative pain control and includes variable clinical situations. In the abdomen and thoracic wall, thoracic ESPB can be applied for pain control after cardiac surgery, video-assisted thoracic surgery, laparoscopic cholecystectomy, and thoracotomy. Recently, favorable postoperative pain control after lumbar spinal or lower limb surgeries has been reported with lumbar ESPB. In addition, ESPB has also been used for chronic pain conditions in the upper and lower extremities. The perfusion index (PI) is a numerical value for the ratio between pulsatile and non-pulsatile blood flow measured by a special pulse oximeter. Although the special probe for PI measurement is relatively more expensive compared with ordinary pulse oximetery probes, its benefit as a marker of peripheral perfusion and as an idex for sympathetic stimulation have increased its use progressively. PI has been used widely for the prediction of success of brachial plexus block or axillary block. Changes of PI ratio value showed an excellent predictive value for the success of block.

There have been no studies demonstrating predictive value of PI in lumbar ESPB ESPB for the relief of low back pain or leg pain due to lumbar disc herniation or stenosis.

Conditions
Pain, Chronic
Being tested
lumbar ESPB group where ESPB is performed at L4 with local anesthetics 20ml
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • lumbar ESPB group where ESPB is performed at L4 with local anesthetics 20mlProcedure or surgery

    ultrasound guided fascial plane injection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perfusion index changes among 4 time periods

    Perfusion index changes among 4 time periods

    Measured: baseline, 10 minutes after erector spinae plane block, 20 minutes after erector spinae plane block, 30 minutes after erector spinae plane block

  2. Number of patients showing numerical rating scale reduction more than 50%

    Number of patients showing numerical rating scale reduction more than 50%

    Measured: 1 month after erector spinae plane block

  3. Number of patients showing numerical rating scale reduction less than 50%

    Number of patients showing numerical rating scale reduction less than 50%

    Measured: 1 month after erector spinae plane block

  4. Number of patients showing no reduction in numerical rating scale

    Number of patients showing no reduction in numerical rating scale

    Measured: 1 month after erector spinae plane block

  5. Back pain functional scale between 2 time periods

    Back pain functional scale between 2 time periods

    Measured: baseline, 1 month after erector spinae plane block

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2023
  2. Study start13 Feb 2023
  3. Primary completion30 Nov 2023 (estimated)
  4. Study completion30 Nov 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
85 participants (estimated)
Target duration
1 Month
IDs, dates and publications
ClinicalTrials.gov ID
NCT05723367
Sponsor's protocol ID
2023-01-025-03
Status last verified
Feb 2023
First submitted
3 Feb 2023
Last updated
15 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hong JH, Park JH, Park KB. Predictors of a Favorable Response to Erector Spinae Plane Block for Lumbosacral Radiculopathy. Pain Physician. 2024 Jan;27(1):89-95.

    PubMed 38285039

Questions about this trial

What is this clinical trial studying?

An observational study of Pain, Chronic, run by Keimyung University Dongsan Medical Center at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ji H Hong (01046794343, swon13@daum.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perfusion index changes among 4 time periods (time frame: baseline, 10 minutes after erector spinae plane block, 20 minutes after erector spinae plane block, 30 minutes after erector spinae plane block). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05723367, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in